{"id": 2354, "input_str": " To boost safety and effectiveness, some changes could be made to the premarket approval supplement pathway through which some high-risk medical devices are cleared for use, according to a commentary in Annals of Internal Medicine.\n\nAlthough first-generation versions of high-risk devices, such as pacemakers, implantable cardioverter-defibrillators (ICDs), and", "correct_token_str": " cardiac", "generated_token_str": " heart", "generator_index": 1, "correct_logprobs": [-9.069696426391602, -3.74470853805542, -3.659379482269287], "generated_logprobs": [-6.303006172180176, -3.6012377738952637, -1.8723081350326538], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}